IDYA

IDEAYA Biosciences, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
39.67
▲ 0.56 (1.43%)
MARKET ·

Price

Open
39.40
Prev close
39.11
Day high
40.56
Day low
39.31
Volume
806.36K
Market cap
$3.83B
P/E (TTM)
52W range
23.23 – 40.58

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+9.28% +10.7%
1M
+9.49% +5.8%
3M
+34.29% +31.2%
6M
+24.05% +13.0%
YTD
+14.75% +2.5%
1Y
+63.12% +43.1%
3Y
+56.98% -17.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$3.83B
Enterprise value$3.03B
Revenue (TTM)$234.13M
Gross profit$-85.24M
EBITDA$-214.20M
Net income$-175.02M
EPS (TTM)$-1.92
Free cash flow$-70.85M
Total cash$828.96M
Total debt$29.31M
Book value / share$12.44
Shares outstanding96.49M
Float90.63M
Short % of float12.21%
Dividend yield
Beta (5Y)-0.09

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-9.66
PEG ratio
Price / sales
Price / book3.19
EV / revenue12.93
EV / EBITDA-14.14
Gross margin-36.41%
Operating margin-1380.73%
Profit margin-74.75%
Return on equity-16.22%
Return on assets-11.54%
Debt / equity2.44
Current ratio10.45
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2025202420232022
Total revenue$218.71M$7.00M$23.39M$50.93M
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$113.70M-$274.48M-$112.96M-$58.66M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -1.05-1.22 -16.2%
Mar 2026 -0.98-1.11 -13.5%
Dec 2025 -0.95-0.94 +0.6%
Sep 2025 -0.551.33 +341.8%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -1.17 13 $6.35M -96.9%
Next quarter -1.13 13 $19.34M +77.8%
Current year -4.61 13 $39.36M -82.0%
Next year -4.11 13 $115.49M +193.5%

Analyst targets & ownership

Account required
Mean target$52.15
High target$65.00
Low target$31.00
Implied upside31.47%
Analyst count13
ConsensusSTRONG BUY
Strong buy / Buy3 / 11
Hold1
Sell / Strong sell0 / 0
Held by insiders2.19%
Held by institutions108.18%
Institutions holding398
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
+50.00K
Net buying
Buy transactions
2
59.55K shares
Sell transactions
1
9.55K shares
Net transactions
+3
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
2.12M
Total on file
Bought 59.55KSold 9.55K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 7, 26
RUIZ BRISENO ANDRES
Officer
CONVERSION 9.55K $122.81K Direct
Jul 7, 26
RUIZ BRISENO ANDRES
Officer
SELL 9.55K $382.13K Direct
Mar 2, 26
STEIN JEFFREY
Director
BUY 50.00K $1.65M Direct
Nov 28, 25
SNYDER DOUGLAS B
General Counsel
STOCK 2.08K $54.65K Direct
Nov 28, 25
RUIZ BRISENO ANDRES
Officer
STOCK 1.94K $60.49K Direct
Feb 18, 25
HATA YUJIRO S.
Chief Executive Officer
CONVERSION 12.81K $250.01K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

4 reporting
NameRelationShares heldLatest
HATA YUJIRO S.
Chief Executive Officer 690.70K Conversion of Exercise of derivative security
RUIZ BRISENO ANDRES
Officer 26.47K Conversion of Exercise of derivative security
SNYDER DOUGLAS B
General Counsel 2.08K Stock Award(Grant)
STEIN JEFFREY
Director 61.01K Purchase

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
37.56
+5.61% from price
SMA 20
36.84
+7.67% from price
SMA 50
35.91
+10.46% from price
SMA 100
32.94
+20.45% from price
SMA 200
33.27
+19.25% from price
EMA 12
37.70
+5.22% from price
EMA 26
36.85
+7.65% from price
EMA 50
35.68
+11.19% from price
RSI (14)
68.8
Neutral
MACD (12,26,9)
0.85
Hist 0.27
ATR (14)
1.19
3.01% of price
Realised vol 30D
29.8%
Annualised
Bollinger upper
39.15
20, 2σ
Bollinger lower
34.54
20, 2σ
50 / 200 cross
Golden
35.91 vs 33.27
Trend bias
Above 200
+19.25%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.97
Less volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
29.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.1%
Peak to trough
Max drawdown 5Y
-69.4%
Peak to trough
ATR 14
1.19
3.01% of price
Beta (reported)
-0.09
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
1.50
Put-heavy session
Put / call open interest
0.77
Positioning, not flow
Max pain
37.50
-5.5% from spot
ATM implied vol
56.0%
Nearest strike to spot
Skew (10% OTM)
+60.3%
Puts bid over calls
Call volume
6
Contracts, this expiry
Put volume
9
Contracts, this expiry
Heaviest call OI
40.00
7 contracts
Heaviest put OI
35.00
7 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 39.67
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.